SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-19-265643
Filing Date
2019-10-10
Accepted
2019-10-10 11:31:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 101405
2 GRAPHIC g637051sp1.jpg GRAPHIC 5812
3 GRAPHIC g637051sp4.jpg GRAPHIC 3023
  Complete submission text file 0001193125-19-265643.txt   114782
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)